|
2025
|
G/S
|
Pharmaceutical preparations and substances; Medicinal preparations and substances; Vaccines. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of vaso-occlusive crisis;; Pharmaceutical preparati... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous syst... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, hormonal... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of blood disorders; Pharmaceutical preparations for... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, endocrine, gastroint... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of Pharmaceutical preparations for the treatment of... |
|
|
G/S
|
Antifungal pharmaceutical preparations; Antiviral pharmaceutical preparations; Anti-inflammatory ... |
|
|
G/S
|
Medical apparatus, namely, infusion and injection devices for administering drugs; Medical syringes |
|
|
G/S
|
Pharmaceutical preparations for the treatment of oncological diseases |
|
|
G/S
|
Pharmaceutical preparations for the treatment of bladder cancer |
|
|
G/S
|
Pharmaceutical preparations and substances. |
|
|
G/S
|
Providing counseling and consulting in the field of healthcare insurance benefits |
|
|
G/S
|
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic ... |
|
|
G/S
|
Veterinary pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central n... |
|
|
G/S
|
Providing medical information in the field of heart disease; Providing information in the field o... |
|
|
Invention
|
Glp-1 receptor agonists and uses thereof.
Provided herein are 6-carboxylic acids of benzimidazol... |
|
|
Invention
|
Process for preparing n-(6-((1h-pyrazol-1-yl)methyl)-4-methoxybenzo[d]isoxazol- 3-yl)-2-methoxybe... |
|
|
Invention
|
Compositions and methods for eliciting an immune response against clostridium difficile.
In one ... |
|
|
Invention
|
Rsv f protein mutants.
The present disclosure relates to RSV F protein mutants, nucleic acids or... |
|
|
Invention
|
Methods of making osivelotor. The present disclosure relates to processes and intermediates that ... |
|
|
Invention
|
Use of anti-cxcr5 antibodies. The invention provides method of using antibodies, and antigen-bind... |
|
|
Invention
|
Immunogenic compositions and methods for eliciting an immune response against clostridioides (clo... |
|
|
Invention
|
Ponsegromab for use in treating cachexia in cancer patients. The invention is directed to methods... |
|
|
Invention
|
Methods of manufacturing a bifunctional compound. This disclosure pertains to the preparation of ... |
|
|
Invention
|
Methods for treatment of inflammatory bowel disease with an anti-tl1a antibody.
The present disc... |
|
|
Invention
|
Methods for treatment of inflammatory bowel disease with an anti-tl1a antibody. The present discl... |
|
|
Invention
|
Coaxial mixing device for nanoparticle preparation and manufacturing equipment including such mix... |
|
|
Invention
|
Substituted pyridine and phenyl compounds. The invention relates to compounds of Formula (I), or ... |
|
|
Invention
|
Aluminum adjuvant nanoparticles, methods of manufacture, and uses thereof. In one aspect, the pre... |
|
|
Invention
|
Method for sterilizing and filling containers for pharmaceutical product and related filling syst... |
|
|
Invention
|
Method and apparatus for improved man-machine interactions.
An automated smart voice-interactive... |
|
|
Invention
|
Method and system of simulating operational integrity of a pre-filled vial.
Method and system of... |
|
|
Invention
|
Method and apparatus for improved human-machine interactions. An automated smart voice-interactiv... |
|
|
Invention
|
Substituted pyridine and phenyl compounds.
The invention relates to compounds of Formula (I), or... |
|
|
Invention
|
Oral compositions/formulations of 2-({4-[(2s)-2-(4-chloro-2-fluorophenyl)-2-methyl-1,3-benzodioxo... |
|
|
Invention
|
Pyrrolidine-based glucose-dependent insulinotropic polypeptide receptor antagonists and uses ther... |
|
|
Invention
|
Glucose-dependent insulinotropic polypeptide receptor antagonists and uses thereof.
Described he... |
|
|
Invention
|
Improved methods for producing glycoconjugates by reductive amination in aprotic solvent. 197Stre... |
|
|
Invention
|
Media and fermentation methods for polysaccharide production in bacterial cell culture. The prese... |
|
|
Invention
|
Nitrogen-containing heterocyclic compounds.
The disclosure relates to compounds of the disclosur... |
|
|
Invention
|
Novel nitrogen-containing heterocyclic compounds. The disclosure relates to compounds of the disc... |
|
|
Invention
|
Tmprss2-erg and rb1 as predictive biomarkers for treatment with a parp inhibitor. This invention ... |
|
|
Invention
|
Methods for producing nucleic acids. in vitroin vitro reaction system. |
|
|
Invention
|
Cdk4 inhibitors for use in the treatment of mantle cell lymphoma. This invention relates to thera... |
|
|
Invention
|
Methods for identifying biomarkers of treatment response and use thereof with a cdk4 inhibitor. M... |
|
|
Invention
|
Cdk4 inhibitors and combinations with cdk2 inhibitors or further agents for use in the treatment ... |
|
|
Invention
|
Polynucleotide compositions and uses thereof. The invention relates to polypeptides and RNA molec... |
|
|
Invention
|
Formulations comprising n-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamide compounds and... |
|
|
Invention
|
Indole analogs. The invention relates to compounds of Formula (I), or pharmaceutically acceptable... |
|
|
Invention
|
Synthesis of (1h-pyrazol-5-yl)cyclopentyl carbamate compounds. This disclosure relates to the nov... |
|
|
Invention
|
Escherichia coli saccharides and uses thereof. E. coliE. coli lipopolysaccharides. In one embodim... |
|
|
Invention
|
Anti-gdf15 antibodies, compositions and methods of use.
The invention provides antibodies, and a... |
|
2024
|
Invention
|
Immunogenic compositions against influenza.
The disclosure relates to compositions and methods f... |
|
|
Invention
|
Immunogenic compositions against influenza.
The invention relates to compositions and methods fo... |
|
2023
|
Invention
|
Lipid compounds and uses thereof.
Compounds are provided having the following structure: (I) or ... |
|
|
Invention
|
Coaxial flow device for nanoparticle preparation and manufacturing equipment including such devic... |
|
|
Invention
|
Systems and methods for performing biological assays using a thermally sealed valve.
Provided he... |
|
|
Invention
|
Dosing regimens of sirp alpha fusion proteins for treatment of cancer.
Dosing regimens and metho... |
|
|
Invention
|
Injection device with a needle detection feature.
The invention relates to an injection device c... |
|
|
Invention
|
Process for producing of vaccine formulations with preservatives.
The present invention relates ... |
|
|
Invention
|
Multi-layered syringe with a threaded connection part and method of manufacturing same.
The inve... |
|
|
Invention
|
Cysteine prototrophy.
Provided herein are cells, compositions, and related methods for improved ... |
|
|
Invention
|
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof.
Th... |
|
2022
|
Invention
|
Enhancement of cd47 blockade therapy with anti-vegf agents.
Various forms of cancer and other di... |
|
|
Invention
|
Ether-linked antiviral compounds.
The invention relates to compounds of Formula I
The inventio... |
